Affiliation:
1. From the Department of Cardiac Surgery, Heart Center, University of Leipzig, Leipzig, Germany (P.M.D., A.V., S.L., M.M., F.W.M.); and Department of Cardiac Surgery, Columbia University, New York, NY (M.A.B.).
Abstract
Background—
Current guidelines do not provide recommendations for optimal timing of coronary artery bypass surgery (CABG) in patients with non–ST-segment–elevation myocardial infarction. Our study aimed to determine the impact of CABG timing on early and late outcomes in patients with non–ST-segment–elevation myocardial infarction.
Methods and Results—
A total of 758 patients underwent CABG within 21 days after non–ST-segment–elevation myocardial infarction between January 2008 and December 2012 at our institution. The patients were divided into 3 groups according to the time interval between symptom onset and CABG: group A, <24 hours (133 patients); group B, 24 to 72 hours (192 patients); and group C, >72 hours to 21 days (433 patients). Predictors of in-hospital and long-term mortality were identified by logistic and Cox regression analyses, respectively. Overall in-hospital mortality was 5.1% (39 patients): 6.0%, 4.7%, and 5.1% in groups A, B, and C (
P
=0.9), respectively. A total of 118 patients died during follow-up. The 5-year survival was 73.1±2%, with a nonsignificant trend toward better survival in groups A (78.2±4%) and C (75.4±3%) compared with group B (63.6±5%; log-rank
P
=0.06). Renal insufficiency and LMD were independent predictors of in-hospital (odds ratio, 3.1;
P
=0.001; and odds ratio, 3.1;
P
=0.002) and long-term mortality (hazard ratio, 1.7;
P
=0.004; and hazard ratio, 1.5;
P
=0.02), whereas administration of P2Y
12
inhibitors was protective (odds ratio, 0.3;
P
=0.01).
Conclusions—
Emergent CABG within 24 hours of non–ST-segment–elevation myocardial infarction is associated with in-hospital mortality and long-term outcomes similar to those of CABG performed after 3 days, despite a higher risk profile. CABG performed between 24 to 72 hours showed a nonsignificant trend toward poorer long-term outcomes. Dual antiplatelet therapy until surgery is beneficial, whereas renal insufficiency and left main disease increase the risk of early and late death.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献